Skip to content

Axon Enterprise

US · AXON #612 by market cap Listed 1970
291.14 -15.84 -5.16%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Valuation each multiple against its own 5-year range

P/B ratio 6.30 Cheap vs history 3rd percentile
5-year average 13.11 · #72 of 92 in Aerospace & Defense
P/E ratio 93.61 Cheap vs history 20th percentile
5-year average 102.28 · forward 100.28 · #47 of 52 in Aerospace & Defense
P/S ratio 6.94 Cheap vs history 1st percentile
5-year average 14.75 · forward 5.50 · #69 of 94 in Aerospace & Defense

Vs. peers Aerospace & Defense

Company Market cap P/E (TTM) P/B Div yield
Axon Enterprise (AXON) 23.71B 93.61 6.30 0.00%
SpaceX (SPCX) 1.74T -505.10 9.82 0.00%
GE Aerospace (GE) 319.95B 36.13 18.26 0.57%
RTX Corp (RTX) 256.62B 30.92 3.71 1.48%
Lockheed Martin (LMT) 130.63B 20.08 12.98 2.44%
Boeing (BA) 123.54B 16.09 18.89 0.00%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★☆☆ Fair value392.09 Economic moatWide UncertaintyMedium

Trading 34.7% below Morningstar's fair value estimate.

Fair value

Though Axon Enterprise Inc appears cheap due to heavy downward pressure in the past year, we have capped its rating at 3 stars to factor in the possibility that it represents a value trap. The stock currently trades at a 22% discount to our quantitative fair value estimate of $392.09 per share; however, some caution is warranted due to this estimate's medium uncertainty rating.

The company's solid growth bolsters our estimated fair value. Consistent revenue and earnings growth indicates a company's potential for increased market share and profitability. Reflecting the firm's growth is its revenue 3-year growth of 32.3%, which ranks in the top 10% compared with global peers. Robust trailing three-year revenue growth portends a favorable future trajectory, which contributes to our view that shares are undervalued.

On a different note, the company's lack of profitability is potentially concerning. Companies with low profitability are often less resilient in recessions and are likely to generate weaker future cash flows for shareholders. The firm's sales yield of 13.1%, a core component of profitability, falls in the bottom 20% globally. This company's inability to generate significant sales growth without meaningful capital investment is a challenge, which, despite our favorable price/fair value ratio, is a negative attribute.

Economic moat

The company's excess returns on capital and superb profitability, which could persist for decades or more, warrant a wide economic moat rating. In addition, the company's moderate financial health score is decent and doesn't seriously concern us with regard to financial distress.

By Quantitative Equity Report

Quote time 2026-11-20 20:02:38 · For reference only, not investment advice and not tailored to your situation.

Axon Enterprise discussion 0 comments

Add a comment